The transcriptome-wide m6A sequencing result of chemoresistant osteosarcoma stem cells revealed that over-expression of METTL3 and low METTL14 expression are associated with doxorubicin chemoresistance and stemness of osteosarcoma cells (70). This evidence concerns the gene METTL14 and osteosarcoma.